MTNB
AMEX · Biotechnology
Matinas Biopharma Holdings I
$0.90
-0.02 (-2.00%)
Open$0.90
Previous Close$0.92
Day High$0.90
Day Low$0.87
52W High$19.50
52W Low$0.81
Volume—
Avg Volume79.8K
Market Cap876.7K
P/E Ratio—
EPS$-1.62
SectorBiotechnology
Analyst Ratings
Strong Sell
7 analysts
Price Target
+4,270.0% upside
Current
$0.90
$0.90
Target
$39.33
$39.33
$22.47
$39.33 avg
$48.65
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 545.4K | 506.2K | 440.2K |
| Net Income | -151,735 | -126,413 | -142,621 |
| Profit Margin | -27.8% | -25.0% | -32.4% |
| EBITDA | -193,711 | -167,268 | -163,365 |
| Free Cash Flow | -191,504 | -185,587 | -103,932 |
| Rev Growth | -0.1% | +13.2% | +21.4% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |